Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check6 days agoChange DetectedA new revision label, v3.5.4, has been added to the study record history, replacing the previous v3.5.3. This indicates an updated version of the record is now current.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedUpdated the site footer “Revision” label on the record history page from v3.5.2 to v3.5.3. This reflects a platform/version change rather than any modification to the underlying trial record history.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry (v3.5.0) was added to the history while an older entry (v3.4.3) was removed, reflecting a platform-level update to how revisions are tracked.SummaryDifference0.1%

- Check78 days agoChange DetectedStudy record history shows Revision: v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page history shows a minor revision from v3.4.1 to v3.4.2; no content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.